NCT01372280View on ClinicalTrials.gov

Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

November 30, 2004

Conditions
Fasting
Interventions
DRUG

Reminyl

Galantamine Hydrobromide Tablets 4 mg

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY